What is the price target for ADN stock?
6 analysts have analysed ADN.CA and the average price target is 18.11 CAD. This implies a price increase of 7.13% is expected in the next year compared to the current price of 16.9.
TSX:ADN • CA0042721005
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACADIAN TIMBER CORP (ADN.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-12-20 | CIBC Capital Markets | Maintains | Neutral -> Neutral |
| 2022-10-27 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-10-27 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-10-25 | Credit Suisse | Downgrade | Neutral |
| 2022-10-14 | CIBC Capital Markets | Downgrade | |
| 2022-10-03 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-09-02 | Credit Suisse | Upgrade | Neutral |
| 2022-07-29 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-07-28 | CIBC Capital Markets | Maintains | Neutral |
| 2022-07-28 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-07-08 | CIBC Capital Markets | Upgrade | Sector Perform |
| 2022-05-05 | Raymond James Capital | Initiate | Outperform |
| 2022-05-05 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-03-21 | CIBC Capital Markets | Maintains | Underperform |
| 2022-02-23 | CIBC Capital Markets | Maintains | Underperform |
| 2022-02-10 | CIBC Capital Markets | Maintains | Underperform |
| 2022-02-10 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-02-10 | Raymond James Financial | Initiate | Outperform |
| 2022-01-12 | Scotiabank Capital | Upgrade | Sector Perform |
| 2022-01-05 | CIBC Capital Markets | Maintains | Underperform |
| 2021-10-29 | Sbank | Upgrade | Sector Perform |
| 2021-10-28 | Raymond James Financial | Initiate | Outperform |
| 2021-10-25 | CIBC World Markets | Downgrade | Underperform |
| 2021-10-21 | CIBC World Markets | Initiate | Underperform |
| 2021-09-20 | CIBC World Markets | Reiterate | Underperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 93.477M 3.29% | 116.185M 24.29% | 86.956M -25.16% | 104.03M 19.64% | 101.91M -2.04% | N/A | |
| EBITDA YoY % growth | 19.929M 9.68% | 24.176M 21.31% | 15.198M -37.14% | 23.483M 54.51% | 27.523M 17.20% | N/A | |
| EBIT YoY % growth | 19.566M 9.31% | 23.659M 20.92% | 13.316M -43.72% | 27.775M 108.58% | 25.553M -8.00% | N/A | |
| Operating Margin | 20.93% | 20.36% | 15.31% | 26.70% | 25.07% | N/A | |
| EPS YoY % growth | 1.72 -18.39% | 1.26 -26.83% | 2.70 114.29% | 0.71 -73.63% | 0.94 32.62% | 1.03 9.45% |
All data in CAD
| Q1 / 26 | Q2 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.12 -42.29% | 0.30 102.00% |
| Revenue Q2Q % growth | 22.725M -8.49% | 25.856M 50.95% |
| EBITDA Q2Q % growth | 4.495M -3.48% | 6.464M 157.02% |
| EBIT Q2Q % growth | 4.141M -6.33% | 8.888M 423.44% |
All data in CAD
6 analysts have analysed ADN.CA and the average price target is 18.11 CAD. This implies a price increase of 7.13% is expected in the next year compared to the current price of 16.9.
ACADIAN TIMBER CORP (ADN.CA) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of ACADIAN TIMBER CORP (ADN.CA) is 0.12 CAD and the consensus revenue estimate is 22.73M CAD.
The number of analysts covering ACADIAN TIMBER CORP (ADN.CA) is 6.